1. Home
  2. CYCN vs IMCC Comparison

CYCN vs IMCC Comparison

Compare CYCN & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • IMCC
  • Stock Information
  • Founded
  • CYCN 2018
  • IMCC 1980
  • Country
  • CYCN United States
  • IMCC Israel
  • Employees
  • CYCN N/A
  • IMCC N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • CYCN Health Care
  • IMCC Health Care
  • Exchange
  • CYCN Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • CYCN 8.4M
  • IMCC 7.5M
  • IPO Year
  • CYCN N/A
  • IMCC N/A
  • Fundamental
  • Price
  • CYCN $3.03
  • IMCC $2.21
  • Analyst Decision
  • CYCN
  • IMCC
  • Analyst Count
  • CYCN 0
  • IMCC 0
  • Target Price
  • CYCN N/A
  • IMCC N/A
  • AVG Volume (30 Days)
  • CYCN 5.8M
  • IMCC 15.7K
  • Earning Date
  • CYCN 03-04-2025
  • IMCC 03-27-2025
  • Dividend Yield
  • CYCN N/A
  • IMCC N/A
  • EPS Growth
  • CYCN N/A
  • IMCC N/A
  • EPS
  • CYCN N/A
  • IMCC N/A
  • Revenue
  • CYCN $194,000.00
  • IMCC $38,042,859.00
  • Revenue This Year
  • CYCN N/A
  • IMCC $22.59
  • Revenue Next Year
  • CYCN N/A
  • IMCC $32.86
  • P/E Ratio
  • CYCN N/A
  • IMCC N/A
  • Revenue Growth
  • CYCN N/A
  • IMCC N/A
  • 52 Week Low
  • CYCN $1.27
  • IMCC $1.61
  • 52 Week High
  • CYCN $9.47
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 45.72
  • IMCC 47.03
  • Support Level
  • CYCN $2.81
  • IMCC $2.11
  • Resistance Level
  • CYCN $4.80
  • IMCC $2.42
  • Average True Range (ATR)
  • CYCN 0.76
  • IMCC 0.18
  • MACD
  • CYCN -0.05
  • IMCC 0.01
  • Stochastic Oscillator
  • CYCN 18.48
  • IMCC 29.09

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: